Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021

Transbound Emerg Dis. 2022 Sep;69(5):e3244-e3249. doi: 10.1111/tbed.14534. Epub 2022 Apr 8.

Abstract

Following findings in Northern America of SARS-CoV-2 infections in white-tailed deer, there is concern of similar infections in European deer and their potential as reservoirs of SARS-CoV-2 including opportunities for the emergence of new variants. UK deer sera were collected in 2020-2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing. There is no evidence that spill-over infections of SARS-CoV-2 occurred from the human population to UK deer or that SARS-CoV-2 has been circulating in UK deer (over the study period). Although it cannot be ruled out, study results indicate that spill-over infections followed by circulation of SARS-CoV-2 to the most common European deer species is small.

Keywords: COVID-19 serological testing; SARS-CoV-2; United Kingdom; deer; sentinel surveillance; viral zoonoses.

MeSH terms

  • Animals
  • Animals, Wild
  • Antibodies, Viral
  • COVID-19 Testing / veterinary
  • COVID-19* / epidemiology
  • COVID-19* / veterinary
  • Deer*
  • Humans
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus

Substances

  • Antibodies, Viral
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2